Clinical Manifestation and Risk Factors Associated With Remission in Patients With Filamentary Keratitis

Am J Ophthalmol. 2020 Oct:218:78-83. doi: 10.1016/j.ajo.2020.05.037. Epub 2020 Jun 20.

Abstract

Purpose: This study investigated the clinical manifestation and risk factors associated with remission in filamentary keratitis.

Design: Retrospective, interventional, comparative case series.

Methods: We retrospectively reviewed the medical records of 116 patients with filamentary keratitis diagnosed and treated between January 2012 and December 2018. We investigated the 5 causative factors including brain lesion, dry eye syndrome, autoimmune disease, ocular surgery or injury, and other conditions; treatment methods and duration; and remission status, and analyzed the risk factors associated with remission.

Results: The mean age of the patients was 56.9 ± 19.1 years and the mean follow-up duration was 14.9 ± 22.8 months. The most common underlying condition associated with filamentary keratitis was identified as a brain lesion (36.2%), followed by dry eye syndrome (30.2%) and autoimmune disease (24.1%). A comparison of remission rates among the causative factors revealed that cases associated with brain lesions had significantly lower remission rates (33.3%) than those associated with other causative factors (>60%) (P = .001). After adjustment for sex, age, diabetes mellitus, and hypertension, the treatment failure rate in patients affected by brain lesions was 6.602-fold higher than that associated without brain lesion (P = .001). The treatment method-dependent differences in the remission rate were observed in brain lesion and dry eye syndrome (P = .041 and P = .005, respectively).

Conclusions: The most common condition leading to filamentary keratitis was a brain lesion, followed by dry eye syndrome and autoimmune disease. The treatment failure rate was statistically significantly low only in patients with filamentary keratitis associated with brain lesions.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / administration & dosage
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Autoimmune Diseases / complications*
  • Brain Diseases / complications*
  • Child
  • Dry Eye Syndromes / complications*
  • Eye Injuries / complications*
  • Female
  • Fluorescein / administration & dosage
  • Follow-Up Studies
  • Free Radical Scavengers / administration & dosage
  • Humans
  • Keratitis / diagnosis*
  • Keratitis / etiology
  • Keratitis / therapy
  • Male
  • Middle Aged
  • Ophthalmologic Surgical Procedures / adverse effects*
  • Remission Induction
  • Retrospective Studies
  • Risk Factors
  • Serum / physiology
  • Slit Lamp Microscopy

Substances

  • Free Radical Scavengers
  • Fluorescein
  • Acetylcysteine